课题基金 / 基金详情

Polymer conjugation to the Feldan Shuttle and its cargo to increase bioavailability in circulation

Polymer conjugation to the Feldan Shuttle and its cargo to increase bioavailability in circulation
聚合物与 Feldan Shuttle 及其货物的结合可提高循环中的生物利用度
批准号:
530982-2018
负责人:
Gauthier, Marc
金额:
$0.91万
依托单位国家:
加拿大
项目类别:
Engage Plus Grants Program
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Gauthier, Marc的其他基金

相似基金

相关文献

中文摘要
翻译
为了使药物有效,它必须能够达到它的目标。许多**药物面临的最大挑战之一是它们的靶点在细胞内。事实上,细胞被一层膜所包围,这层膜将包括药物在内的许多分子拒之门外。即使是最强大的药物,如果不能达到目标也会失效。Feldan Therapeutics公司开发了一种名为Feldan Shuttle的技术,可以促进多种药物进入细胞。他们现在面临着一项技术挑战,这与航天飞机在静脉注射中是否有效有关,而他们自己无法解决这个问题。因此,Feldan Therapeutics Inc.已与INRS的Marc A Gauthier教授联系,研究对航天飞机及其货物进行结构改变,以提高其在循环中的生物利用度。
英文摘要
For a medication to be effective, it must be able to reach its target. One of the greatest challenges for many**drugs is that their targets lie inside cells. Indeed, cells are surrounded by a membrane that keeps many**molecules out - including drugs. Even the most powerful drug will be ineffective if it cannot reach its target.**Feldan Therapeutics Inc. has developed a technology, termed the Feldan Shuttle, which facilitates the transfer**of several types of drugs into cells. They now face a technological challenge, associated with the ability of the**Shuttle to be effective in the context of intravenous injections, that they cannot resolve themselves. As such,**Feldan Therapeutics Inc. has approached Prof Marc A Gauthier of the INRS to investigate structural alterations**to the Shuttle and its cargo to increase their bioavailability in circulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A platform for engineering bi-specific antibody constructs
A platform for engineering bi-specific antibody constructs
Bioconjugate approaches for the systemic delivery of proteins with the Feldan Shuttle
"Click ON/OFF" chemistry via sulfonium-activated groups
海外基金